Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1Phase 1/2 1

Status

Unknown 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5Gastrointestinal 5Other hematologic neoplasm 1

Conditions

Lymphoma 2Virus Diseases 1Paraparesis, Tropical Spastic 1Neuritis 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia-Lymphoma, Adult T-Cell 1Hepatitis B 1HTLV-I Infections 1Burkitt Lymphoma 1

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Tenofovir × Lymphoid × Clear all
NCT07555431 2026-05-04

DOT-H

Fundação Bahiana de Infectologia

Phase 2 Not yet recruiting
146 enrolled
LymphoidOther hematologic neoplasm

Neuritis, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, Paraparesis, Tropical Spastic

NCT04539119 2020-09-04

Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

Ruijin Hospital

Phase 3 Unknown
120 enrolled
Lymphoid

Lymphoma, B-Cell

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown
184 enrolled
Lymphoid

Hepatitis B, Lymphoma

NCT02585947 2016-12-21

To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma

Seoul National University Hospital

Phase 4 Unknown
90 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Non-Hodgkin

NCT01528865 2016-03-11

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma

University of Michigan Rogel Cancer Center

Phase 1/2 Withdrawn
Lymphoid

Lymphoma, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡